Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 56Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Stomach Neoplasms 1Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety 1Lung Neoplasms 1Liver Neoplasms 1Glioma 1Glioblastoma 1Breast Cancer Organoids 1Advanced Gastric Cancer 1

Interventions

Gastrectomy 13Observation 12Gastroscopy 11Drug Therapy 9Surveys and Questionnaires 8Surgical Procedures, Operative 8Endoscopic Mucosal Resection 8Paclitaxel 6Immune Checkpoint Inhibitors 6Blood Specimen Collection 6Tomography, X-Ray Computed 5Oxaliplatin 5Trastuzumab 4Ramucirumab 4Irinotecan 4Immunotherapy 4Hyperthermic Intraperitoneal Chemotherapy 4Cisplatin 4Biopsy 4tislelizumab 3S 1 (combination) 3Robotic Surgical Procedures 3Radiotherapy 3Positron Emission Tomography Computed Tomography 3Nivolumab 3Neoadjuvant Therapy 3Laparoscopy 3Interviews as Topic 3Capecitabine 3taxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Stomach Neoplasms × apatinib × Clear all
NCT06485271 2024-07-03

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

Changzhi People's Hospital Affiliated to Changzhi Medical College

Recruiting
504 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡